Corcept Therapeutics Incorporated (CORT)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	107,282	112,634	124,477	128,202	111,606
Revenue	US$ in thousands	482,375	401,858	365,978	353,874	306,486
Operating profit margin		22.24%	28.03%	34.01%	36.23%	36.41%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $107,282K ÷ $482,375K
= 22.24%

The operating profit margin of Corcept Therapeutics Inc has experienced a declining trend over the past five years, decreasing from 36.41% in 2019 to 22.24% in 2023. This suggests that the company's ability to generate profits from its core operations has weakened over time. Factors contributing to this decline could include increased operating expenses, pricing pressures, or changes in revenue streams. It is important for stakeholders to closely monitor this metric to understand the company's operational efficiency and profitability trends.